Abstract: Background: Trypsin inhibitor (TI) is an enzyme that can be used to treat colorectal cancer because it inhibits the activity of trypsin enzymes that generate NF-KB signaling and MMPs, which promote colorectal cancer cell proliferation, invasion, and metastasis.
Materials and Methods: The data was gathered using Google Scholar, Science Direct, MDPI, and PubMed search engines, as well as data from various published studies on trypsin inhibitors and colorectal cancer.
Results: Trypsin inhibitor......
Key Word: Bowman-birk Inhibitor, Colorectal Cancer, Trypsin Enzyme Inhibitor
[1] S. Pangribowo, "Indonesian Ministry of Health data and information center", 2019
[2] M. Kimman, R. Norman, S. Jan, and D. Kingston, "The Burden of Cancer in Member Countries of the Association of Southeast Asian Nations ( ASEAN )," 2012, doi: 10.7314/APJCP.2012.13.2.411
[3] F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, and A. Jemal, "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries," CA: A Cancer Journal for Clinicians, vol. 68, no. 6, pp. 394–424, 2018, doi: 10.3322/caac.21492.
[4] M. S. Padang and L. Rotty, "Colonic Adenocarcinoma : Case Report," e-CliniC, vol. 8, no. 2, pp. 229–236, 2020, doi: 10.35790/ecl.8.2.2020.30539.
[5] M. I. Sari, I. Wahid, and A. Suchitra, "Adjuvant Chemotherapy In Colorectal cancer," Jurnal Kesehatan Andalas, vol. 8, no. 1S, p. 51, 2019, doi: 10.25077/jka.v8i1s.925.